Data on selected antimalarial drug resistance markers in Zambia

This article describes data on selected resistance markers for antimalarial drugs used in Zambia. Antimalarial drug resistance has hindered the progress in the control and elimination of malaria. Blood samples were collected during a cross-sectional household survey, conducted during the peak malari...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitali, Lungowe, Mwenda, Mulenga C., Miller, John M., Bridges, Daniel J., Hawela, Moonga B., Hamainza, Busiku, Mudenda-Chilufya, Mutinta, Chizema-Kawesha, Elizabeth, Daniels, Rachel, Eisele, Thomas P., Nerland, Audun H., Chipeta, James, Lindtjorn, Bernt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753129/
https://www.ncbi.nlm.nih.gov/pubmed/33364273
http://dx.doi.org/10.1016/j.dib.2020.106650
Descripción
Sumario:This article describes data on selected resistance markers for antimalarial drugs used in Zambia. Antimalarial drug resistance has hindered the progress in the control and elimination of malaria. Blood samples were collected during a cross-sectional household survey, conducted during the peak malaria transmission, April to May of 2017. Dried blood spots were collected during the survey and transported to a laboratory for analysis. The analysed included polymerase chain reaction (PCR) followed by high resolution melt (HRM) for mutations associated with Sulfadoxine-pyrimethamine resistance in the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) and P. falciparum dihydropteroate synthase (Pfdhps) genes. Mutations associated with artemether-lumefantrine resistance in falciparum multi-drug resistance gene 1 (Pfmdr1) were also assessed using PCR and HRM analysis, whereas the P. falciparum Kelch 13 (PfK13) gene was assessed using nested PCR followed by amplicon sequencing.

Ejemplares similares